Discovery of the salicylaldehyde-based compound DDO-02267 as a lysine-targeting covalent inhibitor of ALKBH5
Authors:
- 23 December 2024
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 284, 117183
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- RNA m6Amethylation in cancerMolecular Oncology, 2022
- Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5European Journal of Medicinal Chemistry, 2022
- A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activitiesActa Pharmaceutica Sinica B, 2021
- Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling AxisCell Stem Cell, 2020
- Recent developments of small molecules targeting RNA m6A modulatorsEuropean Journal of Medicinal Chemistry, 2020
- 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell lineBioorganic & Medicinal Chemistry, 2020
- Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid LeukemiaCancer Cell, 2019
- Multiprotein Dynamic Combinatorial Chemistry: A Strategy for the Simultaneous Discovery of Subfamily‐Selective Inhibitors for Nucleic Acid Demethylases FTO and ALKBH3Chemistry – An Asian Journal, 2018
- Lysine‐Targeting Covalent InhibitorsAngewandte Chemie International Edition, 2017
- Targeted Covalent Inhibitors for Drug DesignAngewandte Chemie International Edition, 2016